As abnormal glycometabolism in tumor cells is believed to be inherently related to the overexpression of GLUT1, the expression level of the transporter was taken as an important prognostic indicator of cancer occurrence in the clinic research [16]. This evidence concerns the gene SLC2A1 and neoplasm.